07 September 2021: Clinical Research
Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer
Xue Huang 1ABCDEFG , Mingming Fang 2BCF , Lin Zhu 1BCDF , Cheng Gu 2ABG , Han Cui 3BCDG , Chun Yang 4ACDF* , Yuxing Yang 1ABDF*DOI: 10.12659/MSM.930457
Med Sci Monit 2021; 27:e930457
Figure 1 (A, B) The disease-free survival (DFS) was longer in the extended-field group than in the pelvic-field group (χ2=4.79, P=0.0286). The 3-year survival rate was 86.15% in the extended-field group and 64.29% in the pelvic-field group. There was no significant difference in 3-year overall survival between the 2 groups (χ2=0.10, P=0.7460).